Matching articles for "plaque psoriasis"
Issue 1333 · March 8, 2010 Free
Addendum: Cost of Ustekinumab (Stelara)

In the Medical Letter article on ustekinumab (Stelara) for psoriasis (2010; 52:7) , footnote 2 in table 2 should have included a second sentence: $5595.60 is the cost of one 45-mg syringe.

Med Lett Drugs Ther. 2010 Mar 8; 52(1333):20
In the Medical Letter article on ustekinumab (Stelara) for psoriasis (2010; 52:7) , footnote 2 in table 2 should have included a second sentence: $5595.60 is the cost of one 45-mg syringe.
Issue 1330 · January 25, 2010
Ustekinumab (Stelara) for Psoriasis

The FDA has approved the use of ustekinumab ( Stelara - Centocor Ortho Biotech), an interleukin antagonist given by subcutaneous (SC) injection for treatment of adults with moderate to severe plaque psoriasis.…

Med Lett Drugs Ther. 2010 Jan 25; 52(1330):7-8
The FDA has approved the use of ustekinumab ( Stelara - Centocor Ortho Biotech), an interleukin antagonist given by subcutaneous (SC) injection for treatment of adults with moderate to severe plaque psoriasis. It is the first agent in its class for this indication; the other biologic agents for psoriasis are Tcell or tumor necrosis factor (TNF) inhibitors.
Issue 1231 · March 27, 2006
Clobetasol Propionate (Clobex) Spray for Psoriasis

The FDA has approved a new spray formulation of the super-high-potency corticosteroid clobetasol propionate 0.05% ( Clobex - Galderma) for treatment of moderate to severe plaque psoriasis in adults. Clobetasol…

Med Lett Drugs Ther. 2006 Mar 27; 48(1231):27-8
The FDA has approved a new spray formulation of the super-high-potency corticosteroid clobetasol propionate 0.05% ( Clobex - Galderma) for treatment of moderate to severe plaque psoriasis in adults. Clobetasol propionate is also available as a cream, ointment, gel, solution, foam, lotion and shampoo.